TGFB1 and neoplasm: Donatelli et al. discovered that transforming growth factor β (TGF-β)-–treated human NK cells exhibit reduced tumor cytolysis and abrogated perforin polarization to the immune synapse, losing surface expression of activating killer Ig-like receptor 2DS4 and NKp44.